Cycle duration: Treatment cycles typically span 6 to 12 weeks, subject to reassessment
Nicotinamide Mononucleotide (NMN) or Nicotinamide Riboside (NR): To support NAD+ levels for mitochondrial health
Molecular Characteristics Molecular Type: Synthetic pentadecapeptide research compound Structure: Linear peptide chain (15 amino acids) Stability: High when stored under recommended laboratory conditions Molecular Weight: Sequence-dependent Molecular Stability and Storage Profile Supplied as a lyophilized powder for enhanced long-term stability Long-term storage: Store at 20C to preserve molecular integrity Sensitive to moisture and prolonged light exposure Predictable degradation above room temperature Reconstituted solutions remain stable for approximately 2448 hours under refrigeration Solubility and Reconstitution Characteristics Bacteriostatic water Sterile saline Acidic buffers Compatible analytical-grade organic solvents Technical Specifications product Name BPC-157 10mg cas 137525-51-0 purity 99% (HPLC verified) unit Size 10 mg vial form Lyophilized powder synthesis Solid-Phase Peptide Synthesis (SPPS) analytical HPLC, Mass Spectrometry, UV Spectrophotometry molecular Structure Linear peptide chain stability High when stored under recommended conditions Analytical Validation and Quality Assurance High-Performance Liquid Chromatography (HPLC) purity confirmation Mass Spectrometry (MS) molecular identity and sequence verification UV spectrophotometric concentration analysis Batch identity and consistency verification Endotoxin and microbial contamination screening Regulatory and Compliance Statement BPC-157 10mg is supplied strictly for laboratory research and scientific investigation
This injectable solution provides essential nutritional support for animals suffering from or at risk of vitamin B12 deficiency, helping to maintain overall health and vitality
The problem begins when concerns about your body become difficult to control and start interfering with your relationships, work, health, or daily life
Australia Clinical studies have found that when administered, BPC-157 interacts with multiple biological pathways, making it a regenerative medicine that promotes healing and recovery across various tissues and organs
